![](https://cdn.benzinga.com/files/wuxi-apptec_1_0.jpeg?width=1200&height=800&fit=crop)
WuXi AppTec Posts Lower Profits But Avoids More Share Price Pain
Key Takeaways: U.S. sales dipped slightly, with limited impact for now from a proposed law that could limit Chinese access to the U.S. drugs market, where WuXi AppTec makes nearly two thirds of its revenue China’s drug services companies are cutting prices …